Rachel L Eddy1,2,3, Vanessa M Diamond2, Girija Bhatnagar2, Alexandra Schmidt1, Jonathon A Leipsic1,4, Don D Sin1,3, Bradley S Quon1,3, and Jonathan H Rayment2,5
1Centre for Heart Lung Innovation, St. Paul's Hospital, University of British Columbia, Vancouver, BC, Canada, 2BC Children's Hospital Research Institute, Vancouver, BC, Canada, 3Division of Respiratory Medicine, Department of Medicine, University of British Columbia, Vancouver, BC, Canada, 4Department of Radiology, University of British Columbia, Vancouver, BC, Canada, 5Department of Pediatrics, University of British Columbia, Vancouver, BC, Canada
Synopsis
Keywords: Lung, Hyperpolarized MR (Gas)
Hyperpolarized
129Xe gas MRI (XeMRI) is
gaining traction globally as a primary endpoint in clinical trials, however it
is unknown how images and measurements directly compare across different MRI
scanner platforms. Here we compared same-day ventilation XeMRI across two MRI
manufacturers at two sites in Vancouver Canada in patients with cystic fibrosis
and healthy controls, to determine the interoperability across MRI platforms. Between-site ventilation
images showed strong spatial overlap, and quantitative ventilation defect
percent measurements showed strong agreement across all participants. These
results support the use of XeMRI in multi-center studies irrespective of MRI
platform.
Introduction
Hyperpolarized
129Xe gas MRI (XeMRI) provides a way to sensitively visualize and
measure ventilation abnormalities in people with respiratory disease.1 Although still primarily
a research tool, XeMRI is gaining traction globally as a primary endpoint in
multi-center clinical trials2,3 and for clinical
examinations, with existing approval in the UK and US FDA submission currently under
review.4
Most published XeMRI studies to date however have been single-center, therefore
it is currently unknown how XeMR images and measurements compare across
different MRI platforms. We aimed to compare same-day static ventilation XeMRI
across two MRI manufacturers to determine the cross-platform interoperability
of images and quantitative measurements.Methods
Participants
and Data Acquisition: Participants with cystic
fibrosis (CF) and healthy controls provided written informed consent to
ethics-board-approved protocols and underwent same-day XeMRI at two sites in
Vancouver Canada: BC Children’s Hospital (Site1) and St. Paul’s Hospital
(Site2), approximately 3.9-miles apart by car. Site order was determined by respective
scanner availability and was randomized to the best of our ability. Spirometry
was performed at Site1 only, before or after MRI so as not to be between MRI
studies. Ventilation XeMRI was performed at both sites according to published
guidelines4
with paired anatomical 1H MRI using fast-spoiled gradient-echo
sequences, using a 3.0T Discovery MR750 (GE Healthcare, USA) at Site1 and 3.0T
Magnetom Vida (Siemens Healthineers, Germany) at Site2.
All other imaging
factors were the same across sites, using dedicated equipment at each. 129Xe
gas was polarized using 9820 Hyperpolarizers (Polarean Inc., USA) and 129Xe
images were acquired using flexible vest chest coils (Clinical MR Solutions,
USA). 1H images were acquired using the inherent body coils. Number
of slices for 129Xe/1H MRI was matched between sites.
Participants inhaled a gas mixture from a 1.0L Tedlar-bag from functional
residual capacity and image acquisition was performed under breath-hold
conditions. 129Xe doses (0.45L or 0.50L) and total inhaled gas
volumes (0.85L or 1.0L) were determined by participant height and duplicated
between sites. 129Xe was diluted to the total volume using
ultra-high purity N2 gas, and 1H MRI was performed using
100% medical air.
Data Analysis:
Image
analysis was performed using MATLAB R2021a (Mathworks, USA). Static ventilation
images were segmented by a single observer in a randomized order to generate
ventilation defect percent (VDP) defined as ventilation defect volume
normalized to thoracic cavity volume (TCV).5
The VDP equivalence margin was
pre-defined as the algorithm’s smallest detectable difference of 2%.5
Signal-to-noise ratio (SNR) was calculated on a slice-by-slice basis and
averaged across all slices. Ventilation images from both sites were co-registered
using the modality-independent neighbourhood descriptor (MIND) deformable
registration method6 to quantify
overlap of ventilated regions using the Dice similarity coefficient (DSC).
Deformable registration consisted of voxel-wise similarity measurements of the
MIND of the two images, with diffusion regularization of the deformation field
and optimization using the Gauss-Newton framework. Registration was performed symmetrically
with four levels (downsampling factor 6-4-2-1) so that the algorithm was not
dependent on the choice of the moving/fixed image. Polarization efficiency, SNR,
VDP and TCV were compared between sites using Wilcoxon signed-rank tests. VDP
was further compared using the Spearman correlation coefficient and
Bland-Altman analysis.Results
We evaluated six participants with CF (38-years[28,48], 2F) and three
healthy controls (32-years[29,47], 1F; Table 1). XeMRI was performed across sites within a maximum of 4-hours,41-minutes
(median [interquartile-range (IQR)] 3-hours,0-minutes [2-hours,48-minutes, 4-hours,20-minutes]. Figure 1 shows center-slice XeMRI ventilation at both sites and
corresponding overlap maps for three representative CF participants and one control, demonstrating qualitative agreement in ventilation patterns. DSC
was 94.4 [91.5,96.5] across all participants, 92.9 [91.3,94.4] for CF
participants and 98.1 [97.3,98.4] for controls. Polarization
efficiency (29.1% [27.5,29.4] vs. 37.5% [36.8,38.9], p=0.008) and SNR (62.3
[48.8,77.4] vs. 84.3 [74.2,93.2], p=0.02) were significantly greater at Site2,
however VDP (7.0% [0.2,28.0] vs. 8.2% [0.4,19.7], p=0.7) and TCV (4.7L
[4.1,5.0] vs. 5.0L [4.1,5.1], p=0.09) were not different (Figure 2). VDP was
strongly correlated between sites (ρ=0.93, p<0.001) and Bland-Altman 95%
limits of agreement were [-5.2,7.2] with no significant bias (p=0.2; Figure 3).
Three CF participants and all controls fell within the ±2% equivalence
margin, whereas two CF participants narrowly fell outside the margin (+2.3%,-2.5%)
but within Bland-Altman limits. One CF participant fell outside the Bland-Altman
limits (+8.3%) but underwent an additional same-day XeMRI scan at Site1
30-minutes prior as part of a separate variability investigation (Figure 4).
The ventilation pattern and quantitative VDP differences between the three
same-day images demonstrate the variability likely related to CF
pathophysiology, despite elexacaftor-tezacaftor-ivacaftor therapy. Discussion
In this interim analysis, XeMRI was
qualitatively and quantitatively comparable in same-day investigations across
two sites using different MRI scanner manufacturers, despite different
site-specific 129Xe polarization and SNR. Only one CF participant
fell outside the pre-defined equivalence margin and limits of agreement for
VDP, which could be attributed to CF pathophysiology rather than imaging
factors. Future phantom evaluations7
will help to further objectively characterize similarities and/or differences
between MRI platforms by removing variability caused by pulmonary pathophysiology. Conclusion
XeMRI ventilation and VDP in the same patients
were strongly spatially and quantitatively related across two MRI platforms in
same-day imaging studies, supporting the use of XeMRI in multi-center studies and
as a clinical tool irrespective of MRI platform.Acknowledgements
This work was supported by the CF Foundation.References
1. Mugler, J. P., 3rd & Altes, T. A.
Hyperpolarized 129Xe MRI of the human lung. J
Magn Reson Imaging 37, 313-331,
doi:10.1002/jmri.23844 (2013).
2. ClinicalTrials.gov. BEGIN Novel ImagiNG Biomarkers (BEGINNING),
<https://www.clinicaltrials.gov/ct2/show/NCT05517655> (2022).
3. ClinicalTrials.gov. A Study Of ¹²⁹XE MRI To Assess Disease
Progression In Patients With COPD Treated With Or Without Azithromycin And
Standard-of-Care Medications, <https://www.clinicaltrials.gov/ct2/show/NCT04353661> (2022).
4. Niedbalski, P. J. et al. Protocols for multi-site trials
using hyperpolarized (129) Xe MRI for imaging of ventilation, alveolar-airspace
size, and gas exchange: A position paper from the (129) Xe MRI clinical trials
consortium. Magn Reson Med,
doi:10.1002/mrm.28985 (2021).
5. Kirby, M. et al. Hyperpolarized 3He magnetic
resonance functional imaging semiautomated segmentation. Acad Radiol 19, 141-152,
doi:10.1016/j.acra.2011.10.007 (2012).
6. Heinrich, M. P. et al. MIND: modality independent
neighbourhood descriptor for multi-modal deformable registration. Med Image Anal 16, 1423-1435, doi:10.1016/j.media.2012.05.008 (2012).
7. Bier,
E. A. et al. A thermally polarized
(129) Xe phantom for quality assurance in multi-center hyperpolarized gas MRI
studies. Magn Reson Med 82, 1961-1968, doi:10.1002/mrm.27836
(2019).